Hatteras Closes Fund III

Hatteras Venture Partners of < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Durham, N.C. has closed its third fund with $60 million in capital commitments. The Durham, N.C.-based firm focuses on seed and early-stage opportunities in the pharma, medical device and medical diagnostics spaces. In related news, Hatteras has added two general partners: Robert Ingram, former CEO of GlaxoWellcome, and Douglas Reed, a former partner with Vector Fund Management. www.hatterasvp.com< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />